Eli Lilly has announced that the US Food and Drug Administration (FDA) has approved Foundayo (orforglipron) for adults with obesity or overweight with weight-related medical problems
Diabetes self-management education and support programs are applicable in a variety of practice settings and are intended to keep patients informed about their treatment options, such as how their medications work, administration routes and instructions, dosing frequency, and what to expect with regard to efficacy
Investment If you are considering GLP-1 treatment or are already taking medication and would like a clearer understanding of factors that may influence your long-term success, this assessment can help you move forward with greater clarity and confidence
Your doctor may suggest biomarker tests to help predict your response to certain targeted therapy drugs
Evidence was organized thematically into pharmacokinetics and discontinuation timing, safety of GLP-1 RA exposure in pregnancy, alternative metabolic management strategies, and ethical/clinical considerations
